Sandisk Stock Soars After Blowout Earnings and AI-Driven Outlook 
Rewardy Wallet and 1inch Collaborate to Simplify Multi-Chain DeFi Swaps with Native Token Gas Payments 
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate 
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex 
U.S. Condemns China's Dominance in Global Shipbuilding and Maritime Sectors 
OpenAI Reportedly Eyes Late-2026 IPO Amid Rising Competition and Massive Funding Needs 
Wall Street Rebounds as Investors Eye Tariff Uncertainty, Jobs Report 
SoftBank Eyes Up to $25B OpenAI Investment Amid AI Boom 
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees 
KiwiSaver shakeup: private asset investment has risks that could outweigh the rewards 
Advantest Shares Hit Record High on Strong AI-Driven Earnings and Nvidia Demand 
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use 
Elon Musk’s SpaceX Explores Merger Options With Tesla or xAI, Reports Say 
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case 
Microsoft AI Spending Surge Sparks Investor Jitters Despite Solid Azure Growth 
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns 
Tempus AI Inc (NASDAQ:TEM) shares surged over 18% to $41.62 in after-hours trading following a disclosure by former House Speaker Nancy Pelosi. Pelosi revealed in a recent filing that she had purchased 50 call options on the artificial intelligence-focused precision medicine firm. The options, priced between $50,000 and $100,000, have a $20 strike price and expire on January 16, 2026.
Pelosi’s disclosure also included call options in tech giants Alphabet Inc (NASDAQ:GOOGL), NVIDIA Corporation (NASDAQ:NVDA), and Amazon.com Inc (NASDAQ:AMZN).
The rally comes despite Tempus being down about 12% since its public listing in June 2024. The stock faced pressure last week when a major shareholder sold $33.1 million worth of shares, even after Tempus reported strong 2024 earnings. However, the company flagged a slowdown in contract research organization revenues, sparking some investor caution.
Sentiment around Tempus has turned highly bullish on trading platforms like Stocktwits, with discussions about the stock spiking after Pelosi’s disclosure. The platform reported increased interest and optimism, which contributed to the stock’s strong rally.
Tempus leverages artificial intelligence technology for precision medicine applications, and its growth potential continues to attract attention from prominent investors. This latest move by Pelosi, a well-known and closely watched figure in the investment community, has added momentum to the stock, drawing increased scrutiny from retail and institutional investors alike.
As interest in AI and precision medicine grows, Tempus is positioned as a key player, gaining visibility and market attention.
